Gene Expression Clustering
English
United States, Chicago
GDC
数据描述

The dataset contains clinical data for 25,269 cases, including gene expression data for 20,712 cases, somatic mutation data for 18,640 cases, and data related to protein mutations for 16,508 cases. It includes cohort-level mutation frequency data for 17,771 cases. The data is part of Data Release 41.0 and is considered provisional due to evolving analysis pipelines.
portal.gdc.cancer.gov
IP: 192.170.230.249
加载中...
相关论文
3Prediction of brain metastasis development with DNA methylation signatures
Jeffrey A. Zuccato•Yasin Mamatjan•Farshad Nassiri•Andrew Ajisebutu•Jeffrey C. Liu等 21 人
Nature Medicine
2024
•2024/10/8
•00 p.1-10
Brain metastases (BMs) are the most common and among the deadliest brain tumors. Currently, there are no reliable predictors of BM development from primary cancer, which limits early intervention. Lung adenocarcinoma (LUAD) is the most common BM source and here we obtained 402 tumor and plasma sampl...
CNS cancerDiagnostic markersMethylation analysisNon-small-cell lung cancerPredictive markers
10.1038/S41591-024-03286-Y
ISSN:1078-8956
AI-based histopathology image analysis reveals a distinct subset of endometrial cancers
Amirali Darbandsari•Hossein Farahani•Maryam Asadi•Matthew Wiens•Dawn Cochrane等 20 人
Nature Communications
2024
•2024/6/26
•Vol.15 No.1 p.1-12
Endometrial cancer (EC) has four molecular subtypes with strong prognostic value and therapeutic implications. The most common subtype (NSMP; No Specific Molecular Profile) is assigned after exclusion of the defining features of the other three molecular subtypes and includes patients with heterogen...
Cancer genomicsCancer imagingEndometrial cancerMachine learningPrognostic markers
10.1038/S41467-024-49017-2
ISSN:2041-1723
KiGEP: a quantitative algorithm for calculating human kidney similarity and nephrotoxicity in human kidney organoids
Sugi Lee•Hyun Mi Kang•Jung Hwa Lim•Dae Hun Kim•Kunhyang Park等 10 人
Experimental & Molecular Medicine
2026
•2026/8/3
•00 p.1-10
Kidney organoids (KOs) are being actively developed and used as models for evaluating nephrotoxicity, which is an important process during drug development. To evaluate human pluripotent stem cell-derived KOs, various lineage markers have been used to confirm KO differentiation via quantitative real...
DifferentiationEmbryonic germ cellsInduced pluripotent stem cells
10.1038/S12276-026-01785-1
ISSN:2092-6413